Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria

Ann Lab Med. 2017 Mar;37(2):174-176. doi: 10.3343/alm.2017.37.2.174.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Azabicyclo Compounds / pharmacology*
  • Bacterial Proteins / genetics
  • Ceftazidime / pharmacology*
  • Cephalosporins / pharmacology*
  • DNA, Bacterial / genetics
  • DNA, Bacterial / metabolism
  • Drug Combinations
  • Drug Resistance, Bacterial / drug effects*
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / isolation & purification*
  • Humans
  • Microbial Sensitivity Tests
  • Penicillanic Acid / analogs & derivatives*
  • Penicillanic Acid / pharmacology
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / isolation & purification
  • Real-Time Polymerase Chain Reaction
  • Tazobactam

Substances

  • Anti-Bacterial Agents
  • Azabicyclo Compounds
  • Bacterial Proteins
  • Cephalosporins
  • DNA, Bacterial
  • Drug Combinations
  • avibactam, ceftazidime drug combination
  • ceftolozane, tazobactam drug combination
  • Penicillanic Acid
  • Ceftazidime
  • Tazobactam